731
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and leishmanicidal activity of 2,3,4-substituted-5-imidazolones

, , , , &
Pages 29-37 | Received 15 Jan 2009, Accepted 25 Mar 2009, Published online: 23 Dec 2009

References

  • Tropical Disease Research. Progress 1999-2000. Geneva: World Health Organization, 2001.
  • Olliaro PL, Bryceson ADM. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today 1993;9:323–8.
  • Ram VJ, Nath M. Progress in chemotherapy of leishmaniasis. Curr Med Chem 1996;3:303–28.
  • Croft SL, Yardley V. Chemotherapy of leishmaniasis. Curr Pharm Design 2002;8:319–42.
  • Tempone AG, Perez D, Rath S, Vilarinho AL, Mortara RA, Andrade HF Jr. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine. J Antimicrob Chemother 2004;54:60–8.
  • Siddiqui SA, Bhusare SR, Jarikote DV, Pawar RP, Vibhute YB. New novel synthesis and antibacterial activity of 1-(substituted phenyl)-2-phenyl-4-(3′-halo, 4′-hydroxy 5′-methoxy benzylidene)-imidazole-5-one. Bull Korean Chem Soc 2001;22:1033–6.
  • Wright WB, Brabander JH. The rearrangement and cyclization of Ethyl N-(methylaminoalkyl) carbanilates and 1,1-dimethyl-3-methylaminoalkyl-3-phenylureas. J Org Chem 1961;26:4051–7.
  • Niedbalia V, Buettcher I. Imidazole derivatives for pharmaceutical preparations. Chem Abstr 1981;94:15732.
  • Pande K, Kalsi KR, Bhalla TN, Barthwal JP. Some newer imidazolones and their anti-inflammatory activity. Pharmazie 1987;42:269.
  • Wright WB, Brabander HS, Hardy RA, Osterberg AC. Central nervous system depressants I. 1-Aminoalkyl-3-aryl derivatives of 2-imidazolidinone, 2-imidazolidinethione, and tetrahydro-2(1H)-pyrimidinone. J Med Chem 1966;9:852–6.
  • Lingi A, Alfonso M, Pierluigi R, Afro G, Enzo Z, Nicola DT, et al. Derivatives of imidazole. III. Synthesis and pharmacological activities of nitriles, amides, and carboxylic acid derivatives of imidazo[1,2-a]pyridine. J Med Chem 1969;12:122–6.
  • Brik F, Godefrot, Reatge J. DL-1-(α-Methylbenzyl)-2-methylimidazole-5-carboxylate esters. Synthesis and pharmacological properties. J Med Chem 1972;15:336–7.
  • Verma M, Charturvedi AK, Chaudhary A, Parmar SS. Monoamine oxidase inhibitory and anticonvulsant properties of 1, 2, 4-trisubstituted 5-imidazolones. J Pharm Sci 1974;463:1740–4.
  • Upadhyay P, Pandya A, Parekh H. Possible anticonvulsant imidazloinones. Synthesis and anticonvulsant activity of 1N-(γ′-picolinyl)-4-subsituted-benzylidene-2-methyl/phenyl-5-imidazolinone. J Indian Chem Soc 1991;68:296–8.
  • Bhalla M, Naithani PK, Bhalla TN, Saxena AK, Shanker K. Novel imidazole congeners as anti-inflammatory agents. J Indian Chem Soc 1992;69:594–5.
  • Mesaik MA, Khan KM, Zia-Ullah, Rahat S, Choudhary MI, Murad S, et al. Immunomodulatory properties of synthetic imidazolone derivatives. Lett Drug Des Discov 2005;2:490–6.
  • Salma U, Mazhar M, Imtiaz-ud-Din, Ali S, Khan KM. In vitro antileishmanial activities of germatarnyl and silicon incorporated diorganotin derivatives: synthesis and spectroscopic properties. J Enzyme Inhib Med Chem 2009;23:413–19.
  • Khan KM, Mughal UR, Samreen, Perveen S, Choudhary MI. Schiff bases of isatin: potential anti-leishmanial agents. Lett Drug Des Discov 2008;5:243–9.
  • Khan KM, Ahmed S, Khan ZA, Zia-Ullah, Rani M, Choudhary MI, et al. In vitro leishmanicidal activity of 3-substituted isocoumarins: synthesis and structure-activity relationship. Med Chem 2008;4:163–9.
  • Khan KM, Rasheed M, Zia-Ullah, Hayat S, Kaukab F, Choudhary MI, et al. Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogs. Bioorg Med Chem 2003;11:1381–7.
  • (a) A ratio of 1:10 of oxazolone to PPA was used to get E-isomer; (b) Rao YS. A new stereospecific synthesis of the E isomers of 2-phenyl-4-arylmethylene-2-oxazolin-5-ones. J Org Chem 1976;41:722–725.
  • Khan KM, Mugal UR, Khan MTH, Zia-ullah, Perveen S, Choudhary MI. Oxazolones: new tyrosinase inhibitors; synthesis and their structure-activity relationships. Bioorg Med Chem 2006;14:6027–33.
  • Khan KM, Mugal UR, Lodhi MA, Choudhary MI. Synthesis and chymotrypsin inhibitory activity of substituted oxazolones. Lett Drug Des Discov 2008;5:52–6.
  • Atta-ur-Rahman, Choudhary MI, Thomsen WJ. Bioassay Techniques for Drug Development. Amsterdam: Harwood Academic Publishers, 2001:60–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.